Cochrane Abstracts
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma New
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chimeric Antigen Receptor (CAR) T‐cell Therapy for People With Relapsed or Refractory Diffuse Large B‐cell Lymphoma New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma_New. Accessed 06 June 2023.
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma_New. Accessed June 6, 2023.
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma_New
Chimeric Antigen Receptor (CAR) T‐cell Therapy for People With Relapsed or Refractory Diffuse Large B‐cell Lymphoma New [Internet]. In: Cochrane Abstracts. [cited 2023 June 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma New
ID - 431170
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma_New
DB - Evidence Central
DP - Unbound Medicine
ER -
